Operating Lease, Right-of-Use Asset of Inhibrx Biosciences, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Inhibrx Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Inhibrx Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $6,004,000, a 294% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Inhibrx Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $6,004,000 +$4,479,000 +294% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $6,460,000 +$4,449,000 +221% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $6,904,000 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $7,338,000 +$4,386,000 +149% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $1,525,000 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $2,011,000 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q4 2023 $2,952,000 31 Dec 2023 10-K 17 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.